Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patients
{{output}}
We investigated the effects of pharmacogenetic variations and efavirenz pharmacokinetics on inter-individual differences in the extent of CYP3A induction by efavirenz using 4β-hydroxycholesterol/cholesterol (4β-OHC/Chol) as a marker for CYP3A induction. Plas... ...
